NHS

NHS hospitals are set to adopt an AI-powered blood test to improve womb cancer diagnostics for women with heavy bleeding. Developed by PinPoint Data Science, the test analyzes blood markers to stratify risk into low, elevated, or high categories. This could spare up to one in five women from invasive procedures like transvaginal ultrasounds, streamlining care and freeing up GP capacity. The AI tool has shown high accuracy in trials and is part of a broader NHS push towards AI integration.

AI-powered remote monitoring is revolutionizing NHS care, enhancing efficiency and patient independence. Companies like Doccla utilize virtual wards and machine learning to predict patient deterioration, enabling proactive interventions. This technology has led to significant reductions in hospital bed days and GP appointments, while also offering substantial cost savings. By automating tasks and providing personalized insights, AI empowers clinicians and supports patients in managing their health at home, aligning with the NHS’s vision for future healthcare delivery.